ClinicalTrials.Veeva

Menu

Prevention of Postpartum Haemorrhage

B

Benha University

Status

Unknown

Conditions

Post Partum Hemorrhage

Treatments

Drug: Tranexamic acid injection

Study type

Interventional

Funder types

Other

Identifiers

NCT04463966
Tranexamic

Details and patient eligibility

About

Use of Tranexamic Acid for prevention of Postpartum hemorrhage in high risk patients: Randomized Control Trial

Full description

This study aims to assess the efficacy of administration of Tranexamic Acid in preventing Postpartum haemorrhage & reducing intraoperative and postoperative blood loss in high risk women for Postpartum Hemorrhage undergoing caesarean section. Studying its benefit to transfusion-sparing and hysterectomy-sparing. & reduction of hemorrhage-related mortality when Postpartum hemorrhage is expected.

Enrollment

100 estimated patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women at high risk for postpartum hemorrhage after cesarean section

Exclusion criteria

  • women who are not at high risk for postpartum hemorrhage , or attending for normal vaginal delivery.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Study
Active Comparator group
Description:
Tranexamic acid 1 gm (100 mg/ml) slowly intravenous infusion during delivery ( administered over 10 minutes at 1 ml/minute) .
Treatment:
Drug: Tranexamic acid injection
Control
No Intervention group
Description:
control group will not be given tranexamic acid

Trial contacts and locations

1

Loading...

Central trial contact

Aboubakr Elnashar, MD; shaimaa ezzat

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems